Home » Topics » Disease categories and therapies » Immune

Immune
RSS

ACE-393 completes phase I trials for travelers' diarrhea

April 2, 2007

Carrington and IVI collaborate on sublingual vaccine development

April 2, 2007

GSK files Globorix meningococcal vaccine

March 30, 2007

Phase IIb kidney transplant trial of ISA-247 clears interim review

March 30, 2007

orBec cleared for phase II study in prevention of GVHD

March 28, 2007

Quinvaxem vaccinations in Ethiopia

March 27, 2007

Medistem introduces Tolerostem as second pipeline candidate

March 23, 2007

Recent patent literature covers new drugs for the treatment of immunological disorders.

March 23, 2007

GenVec and NIAID sign CRADA for RSV vaccine development

March 22, 2007

New data suggest utility of Homspera as cotherapeutic agent

March 22, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...